Skip to content

A multicenter, first-in-human study to investigate a venipuncture device prototype and assess its safety and feasibility

A multicenter, first-in-human study to investigate a venipuncture device prototype and assess its safety and feasibility - Feasibility of a venipuncture device prototype

Status
Unknown
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON47958
Enrollment
82
Registered
2019-05-16
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

de venapunctie blood drawing venipuncture

Interventions

Automated venipuncture by the VDPA in one arm

Sponsors

Vitestro B.V.
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: * Age *18 years. * Written signed informed consent must be obtained. * Able to participate in this study

Exclusion criteria

Exclusion criteria: A potential subject who meets any of the following criteria will be excluded from participation in this study: * Unable to follow instructions. * Previous chemotherapy or intravenous drug use * Diseases that are associated with poor vein conditions, such as hemophilia * Coagulation disorders or use of anticoagulants * Contra-indications for venipuncture in the cubital fossa (e.g. due to local skin disease, burns, edema, hematoma, previous lymph node extirpation, an arteriovenous fistula, or a paretic/ paralyzed arm) * Recurrent vasovagal reactions during venipuncture * Tattoos in the cubital fossa

Design outcomes

Primary

MeasureTime frame
Feasibility: Number of successful automated venipunctures Safety: number of adverse events and number of adverse device events

Secondary

MeasureTime frame
Subject's pain experience Duration of device procedure in seconds Causes of missed venipuncture

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)